Short answer · Medically reviewed summary · Last updated: 2026-04-06
Stevens-Johnson Syndrome (SJS) is primarily triggered by an adverse immune reaction to medications, most commonly involving a T-cell-mediated hypersensitivity response that leads to the widespread destruction of skin and mucous membrane cells. The Mechanism of SJS Think of the immune system in Stevens-Johnson Syndrome as a security system that mistakenly identifies a benign substance—usually a drug—as a dangerous intruder. When a person with a specific genetic predisposition takes a triggering medication, their immune system launches an aggressive, "over-the-top" defense.
4 people with Stevens Johnson Syndrome have shared their first-person experience on this question at DiseaseMaps.
Stevens-Johnson Syndrome (SJS) is primarily triggered by an adverse immune reaction to medications, most commonly involving a T-cell-mediated hypersensitivity response that leads to the widespread destruction of skin and mucous membrane cells.
Think of the immune system in Stevens-Johnson Syndrome as a security system that mistakenly identifies a benign substance—usually a drug—as a dangerous intruder. When a person with a specific genetic predisposition takes a triggering medication, their immune system launches an aggressive, "over-the-top" defense. This causes cytotoxic T-cells to release proteins that trigger apoptosis, or programmed cell death, in the keratinocytes (the cells that make up the outer layer of your skin). This is why Stevens-Johnson Syndrome often presents as a severe, blistering rash that resembles a chemical burn.
While the medication acts as the trigger, our genetic blueprint often determines who is at risk. Research has identified specific human leukocyte antigen (HLA) alleles—such as HLA-B*15:02 in individuals of Han Chinese descent taking carbamazepine—that significantly increase susceptibility to Stevens-Johnson Syndrome. Beyond genetics, other environmental triggers include viral infections like Mycoplasma pneumoniae, though drug-induced cases remain the most clinically documented etiology.
In medical research, we distinguish between a cause (the drug that initiates the immune cascade) and a risk factor (the genetic marker that makes your immune system "primed" to overreact). You can have the risk factor and never develop Stevens-Johnson Syndrome, but the combination of the specific medication and the genetic predisposition is what typically leads to the onset of the disease.
Current research is focused on pharmacogenomics—testing for these genetic markers before prescribing high-risk medications to prevent Stevens-Johnson Syndrome from ever occurring. Scientists are also investigating the specific signaling pathways that T-cells use to attack the skin, hoping to find targeted therapies that can stop the reaction without suppressing the entire immune system.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.